Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,353 public trials 3,272 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Active, not recruiting

Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

NCT04068194

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +24 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 46 locations
View Trial Details
Active, not recruiting

Treatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal Stents

NCT06453590

Conditions
Bile Duct Cancer, Bile Duct Diseases, Bile Duct Neoplasms, +20 more
Locations
  • Danderyds hospital Danderyd, Sweden
  • Sahlgrenska University hospital Gothenburg, Sweden
  • Central Hospital Karlstad Karlstad, Sweden
  • University Hospital Lund Lund, Sweden
View Trial Details
Active, not recruiting

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

NCT04557449

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Breast Diseases, +33 more
Locations
  • Ellison Institute Los Angeles, California, United States
  • Yale-New Haven Hospital-Yale Cancer Center New Haven, Connecticut, United States
  • Smilow Cancer Hospital Phase 1 Unit New Haven, Connecticut, United States
  • Brigham & Women's Hospital Boston, Massachusetts, United States
View all 39 locations
View Trial Details
Active, not recruiting

A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)

NCT04008030

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Local Institution - 0059 Los Angeles, California, United States
  • Local Institution - 0130 Sacramento, California, United States
  • Local Institution - 0103 Denver, Colorado, United States
  • Local Institution - 0119 Arlington Heights, Illinois, United States
View all 157 locations
View Trial Details

Related conditions